Correlation Between Sirona Biochem and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sirona Biochem and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sirona Biochem and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sirona Biochem Corp and NervGen Pharma Corp, you can compare the effects of market volatilities on Sirona Biochem and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sirona Biochem with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sirona Biochem and NervGen Pharma.

Diversification Opportunities for Sirona Biochem and NervGen Pharma

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Sirona and NervGen is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sirona Biochem Corp and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Sirona Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sirona Biochem Corp are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Sirona Biochem i.e., Sirona Biochem and NervGen Pharma go up and down completely randomly.

Pair Corralation between Sirona Biochem and NervGen Pharma

Assuming the 90 days horizon Sirona Biochem is expected to generate 2.59 times less return on investment than NervGen Pharma. In addition to that, Sirona Biochem is 2.1 times more volatile than NervGen Pharma Corp. It trades about 0.01 of its total potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.03 per unit of volatility. If you would invest  200.00  in NervGen Pharma Corp on September 4, 2024 and sell it today you would earn a total of  3.00  from holding NervGen Pharma Corp or generate 1.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sirona Biochem Corp  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
Sirona Biochem Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sirona Biochem Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Sirona Biochem is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
NervGen Pharma Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Sirona Biochem and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sirona Biochem and NervGen Pharma

The main advantage of trading using opposite Sirona Biochem and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sirona Biochem position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind Sirona Biochem Corp and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges